Buprenorphine Tablet
Product Images NDC 62756-459

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 62756-459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-label-2mg (Buprenorphine Label 2mg)

This is a label for Buprenorphine Sublingual Tablets with NDC number 62756-459-83 and a quantity of 30 tablets. The label instructs the pharmacist to dispense with medication guide for each patient. It also mentions that the package is open for full labeling.*

FDA Label Image

Buprenorphine-label-8mg (Buprenorphine Label 8mg)

This is a label for buprenorphine sublingual tablets with NDC number 62756-460-83. The pharmacist is advised to dispense the medication with a medication guide to each patient. The label also includes a lot number (AAAAEHA) and an expiration date (MMYYYY). The dosage strength is not entirely clear, but may be between 5-8mg H.*

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.